Central Pharmaceutical JSC No2 (HSTC:DP2) Net-Net Working Capital: ₫0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSTC:DP2 Central Pharmaceutical JSC No2 HSTC:DP2
23 GF Score
Price ₫4,900.00
View Full Analysis

What is Central Pharmaceutical JSC No2 Net-Net Working Capital?

Central Pharmaceutical JSC No2 HSTC:DP2 23 Net-Net Working Capital is ₫0.00 as of . 20. GuruFocus rates HSTC:DP2 with a GF Score™ of 23/100.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Central Pharmaceutical JSC No2's Net-Net Working Capital for the quarter that ended in . 20 was ₫0.00.

The industry rank for Central Pharmaceutical JSC No2's Net-Net Working Capital or its related term are showing as below:

HSTC:DP2's Price-to-Net-Net-Working-Capital is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 7.67
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Central Pharmaceutical JSC No2  (HSTC:DP2) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Central Pharmaceutical JSC No2 Net-Net Working Capital Related Terms


Central Pharmaceutical JSC No2 Net-Net Working Capital Historical Data

* Premium members only.

The historical data trend for Central Pharmaceutical JSC No2's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central Pharmaceutical JSC No2 Net-Net Working Capital Chart

Central Pharmaceutical JSC No2 Annual Data
Trend
Net-Net Working Capital

Central Pharmaceutical JSC No2 Semi-Annual Data
Net-Net Working Capital

HSTC:DP2 vs : Net-Net Working Capital Comparison

For the Pharmaceutical Retailers subindustry, Central Pharmaceutical JSC No2's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Central Pharmaceutical JSC No2 Price-to-Net-Net-Working-Capital vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Central Pharmaceutical JSC No2's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Central Pharmaceutical JSC No2's Price-to-Net-Net-Working-Capital falls into.


HSTC:DP2
23GF Score
Central Pharmaceutical JSC No2 HSTC:DP2
Net-Net Working Capital is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Central Pharmaceutical JSC No2 Net-Net Working Capital Calculation

Central Pharmaceutical JSC No2's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in . 20 is calculated as

Central Pharmaceutical JSC No2's Net-Net Working Capital (NNWC) per share for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.

What does a Net-Net Working Capital of ₫0.00 mean?
Central Pharmaceutical JSC No2 (HSTC:DP2) has a Net-Net Working Capital of ₫0.00 as of . 20. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on Central Pharmaceutical JSC No2
Is Central Pharmaceutical JSC No2's Net-Net Working Capital too high?
Central Pharmaceutical JSC No2's current Net-Net Working Capital is ₫0.00. Overall, Central Pharmaceutical JSC No2 has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Central Pharmaceutical JSC No2's Net-Net Working Capital compare to ?
Central Pharmaceutical JSC No2's Net-Net Working Capital of ₫0.00 can be compared against companies in the Healthcare Providers & Services industry. The industry median Net-Net Working Capital is 7.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net-Net Working Capital for a Healthcare Providers & Services company?
The median Net-Net Working Capital among Healthcare Providers & Services companies is 7.67, based on 197 companies in the industry. Companies in the top quartile (top 25%) have a Net-Net Working Capital significantly above this median, while those in the bottom quartile fall well below. However, Net-Net Working Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net-Net Working Capital mean?
A high Net-Net Working Capital can signal that a stock is expensive relative to its fundamentals. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on Central Pharmaceutical JSC No2 For the Healthcare Providers & Services industry, the median Net-Net Working Capital is 7.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Central Pharmaceutical JSC No2's current Net-Net Working Capital is ₫0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Central Pharmaceutical JSC No2 stock overvalued right now?
Central Pharmaceutical JSC No2 (HSTC:DP2) has a current Net-Net Working Capital of ₫0.00. The current Net-Net Working Capital is ₫0.00. Central Pharmaceutical JSC No2's overall GF Score™ is 23/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net-Net Working Capital calculated?
Net-Net Working Capital is calculated from a company's financial statements. For Central Pharmaceutical JSC No2 (HSTC:DP2), the current Net-Net Working Capital is ₫0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Central Pharmaceutical JSC No2 Business Description

Comparable Companies
Address No. 9 Tran Thanh Tong, Bach Dang Ward, Hai Ba Trung District, Hanoi, VNM
Central Pharmaceutical JSC No2 is engaged in the Trading of medicinal materials, pharmaceutical materials, chemicals, essential oils, modern medicines, traditional medicine drugs, cosmetics, and nutritious foods. Some of its products include Gentamycin injection solution 80; Genatreson Skin Cream; Ferimax Hard Capsules and others.
23GF Score

Get the complete analysis for HSTC:DP2

Net-Net Working Capital is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫4,900.00
Price